Literature DB >> 25220465

Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism.

Teruhito Yoshitaka1, Tomoyuki Mukai1, Mizuho Kittaka1, Lisa M Alford1, Salome Masrani1, Shu Ishida2, Ken Yamaguchi3, Motohiko Yamada3, Noriyoshi Mizuno2, Bjorn R Olsen4, Ernst J Reichenberger5, Yasuyoshi Ueki6.   

Abstract

Cherubism is caused by mutations in SH3BP2. Studies of cherubism mice showed that tumor necrosis factor α (TNF-α)-dependent autoinflammation is a major cause of the disorder but failed to explain why human cherubism lesions are restricted to jaws and regress after puberty. We demonstrate that the inflammation in cherubism mice is MYD88 dependent and is rescued in the absence of TLR2 and TLR4. However, germ-free cherubism mice also develop inflammation. Mutant macrophages are hyperresponsive to PAMPs (pathogen-associated molecular patterns) and DAMPs (damage-associated molecular patterns) that activate Toll-like receptors (TLRs), resulting in TNF-α overproduction. Phosphorylation of SH3BP2 at Y183 is critical for the TNF-α production. Finally, SYK depletion in macrophages prevents the inflammation. These data suggest that the presence of a large amount of TLR ligands, presumably oral bacteria and DAMPs during jawbone remodeling, may cause the jaw-specific development of human cherubism lesions. Reduced levels of DAMPs after stabilization of jaw remodeling may contribute to the age-dependent regression.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220465      PMCID: PMC4177302          DOI: 10.1016/j.celrep.2014.08.023

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  54 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

3.  Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.

Authors:  Noam Levaot; Oleksandr Voytyuk; Ioannis Dimitriou; Fabrice Sircoulomb; Arun Chandrakumar; Marcel Deckert; Paul M Krzyzanowski; Andrew Scotter; Shengqing Gu; Salima Janmohamed; Feng Cong; Paul D Simoncic; Yasuyoshi Ueki; Jose La Rose; Robert Rottapel
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

Review 4.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 5.  Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics.

Authors:  Jean-Laurent Casanova; Laurent Abel; Lluis Quintana-Murci
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 6.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

7.  NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.

Authors:  Antonios O Aliprantis; Yasuyoshi Ueki; Rosalyn Sulyanto; Arnold Park; Kirsten S Sigrist; Sudarshana M Sharma; Michael C Ostrowski; Bjorn R Olsen; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2008-10-09       Impact factor: 14.808

8.  The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response.

Authors:  Grace Chen; Ioannis D Dimitriou; Jose La Rose; Subburaj Ilangumaran; Wen-Chen Yeh; Gina Doody; Martin Turner; Jennifer Gommerman; Robert Rottapel
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Growth hormone, inflammation and aging.

Authors:  Michal M Masternak; Andrzej Bartke
Journal:  Pathobiol Aging Age Relat Dis       Date:  2012-04-04

10.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  23 in total

1.  Investigating global gene expression changes in a murine model of cherubism.

Authors:  Tulika Sharma; Justin Cotney; Vijender Singh; Archana Sanjay; Ernst J Reichenberger; Yasuyoshi Ueki; Peter Maye
Journal:  Bone       Date:  2020-03-10       Impact factor: 4.398

2.  Osteoimmunology in 2014: Two-faced immunology-from osteogenesis to bone resorption.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

3.  Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.

Authors:  Mizuho Kittaka; Kotoe Mayahara; Tomoyuki Mukai; Tetsuya Yoshimoto; Teruhito Yoshitaka; Jeffrey P Gorski; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

4.  Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Robert Rottapel; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.741

Review 5.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

6.  Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.

Authors:  Tetsuya Yoshimoto; Tatsuhide Hayashi; Toshio Kondo; Mizuho Kittaka; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2018-05-22       Impact factor: 6.741

7.  Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.

Authors:  Teruhito Yoshitaka; Mizuho Kittaka; Shu Ishida; Noriyoshi Mizuno; Tomoyuki Mukai; Yasuyoshi Ueki
Journal:  Bone       Date:  2014-10-31       Impact factor: 4.398

8.  Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.

Authors:  Virginie Prod'Homme; Laurent Boyer; Nicholas Dubois; Aude Mallavialle; Patrick Munro; Xavier Mouska; Isabelle Coste; Robert Rottapel; Sophie Tartare-Deckert; Marcel Deckert
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

9.  Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.

Authors:  Prokopios P Argyris; Rajaram Gopalakrishnan; Ying Hu; Ernst J Reichenberger; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2017-07-18

Review 10.  Osteoimmunology: evolving concepts in bone-immune interactions in health and disease.

Authors:  Masayuki Tsukasaki; Hiroshi Takayanagi
Journal:  Nat Rev Immunol       Date:  2019-06-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.